In the present study, studies conducted from 1995 till 2009 were taken and meta-analysis was performed to clarify the consistency in trends of biomarkers CSF tau and Aβ42 in different types of dementias and whether the same can be used as diagnostic biomarkers for early diagnosis of AD. This evidence concerns the gene MAPT and dementia.